// App-Quantinova.ai

THU0149 : TREAT TO TARGET EARLY RHEUMATOID ARTHRITIS CLINIC: HIGH RATES OF REMISSION AND LOW DISEASE ACTIVITY ON TREATMENT WITH CONVENTIONAL DISEASE MODIFYING DRUGS

Researchers

Presenter

  • O. Semenova

Principal Investigators

  • H. Thompson

  • S. Kallankara

  • O. Olabambo

  • Y. Patel

  • E. Baguley

Medical Centers

  • Hull and York Medical School, University of Hull, Hull, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • HWA-486

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved